Understanding how T cells change in a specific type of kidney cancer.
Elucidating T Cell Ferroptosis in Renal Medullary Carcinoma: 3D Genome Architecture Rewiring and Therapeutic Alleviation
This study is looking at how the structure of DNA in T cells changes in people with a rare kidney cancer called renal medullary carcinoma, especially in those with sickle cell disease, to help find better treatments and improve cancer care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10977137 on NIH RePORTER |
What this research studies
This research investigates the three-dimensional structure of chromatin in T cells and how it is affected by the tumor environment in renal medullary carcinoma (RMC), a rare and aggressive kidney cancer. Using a technique called Hi-C, the researchers aim to identify the unique chromatin structures in T cells from patients with sickle cell disease compared to healthy individuals. By exploring these changes, the study seeks to uncover how they influence cancer outcomes and the effectiveness of immune therapies. The ultimate goal is to improve treatment options for patients suffering from RMC.
Who could benefit from this research
Good fit: Ideal candidates for this research include young individuals of African descent, particularly those with sickle cell disease who are diagnosed with renal medullary carcinoma.
Not a fit: Patients with renal medullary carcinoma who do not have sickle cell disease or those with other types of kidney cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective immunotherapies for patients with renal medullary carcinoma.
How similar studies have performed: While the specific approach of examining 3D chromatin architecture in T cells in the context of RMC is novel, similar studies in other cancers have shown promising results.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Yang, Liuqing — University of Tx Md Anderson Can Ctr
- Study coordinator: Yang, Liuqing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.